#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13534	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2142	628.8	0	.	n	.	0	C207T	SNP	207	207	C	491	491	T	767	T,C	534,184	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13534	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2142	628.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1468	1468	C	731	C,T	691,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24616	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3514	698.0	0	.	n	.	0	T695C	SNP	695	695	T	1008	1008	C	715	C,G,A	669,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24616	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3514	698.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1951	1951	G	754	G,A	708,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24616	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3514	698.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2284	2284	C	787	C	744	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24616	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3514	698.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2358	2358	A	758	A	715	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24616	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3514	698.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2910	2910	C	744	C,A	706,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1864	folP	855	855	100.0	folP.l15.c30.ctg.1	1433	129.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1005	1007	AGC	185;184;185	A;G;C	176;174;170	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4968	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3550	139.6	1	SNP	p	S91F	1	.	.	271	273	TTC	629	631	TTC	146;145;145	T;T;C	141;140;141	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4968	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3550	139.6	1	SNP	p	D95G	1	.	.	283	285	GGC	641	643	GGC	137;135;131	G;G;C	133;129;125	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4968	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3550	139.6	1	SNP	p	G95N	0	.	.	283	285	GGC	641	643	GGC	137;135;131	G;G;C	133;129;125	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1566	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1194	129.3	1	SNP	p	G45D	0	.	.	133	135	GGC	423	425	GGC	189;188;190	G;G;C	179;179;180	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	808	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1142	70.5	0	.	n	.	0	A197.	DEL	197	197	A	654	654	A	178	A	169	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2930	173.2	1	SNP	p	D86N	0	.	.	256	258	GAC	615	617	GAC	202;201;200	G;A;C	188;184;191	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2930	173.2	1	SNP	p	S87R	1	.	.	259	261	CGT	618	620	CGT	201;203;204	C,A;G;T	190,1;192;192	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2930	173.2	1	SNP	p	R87W	0	.	.	259	261	CGT	618	620	CGT	201;203;204	C,A;G;T	190,1;192;192	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2930	173.2	1	SNP	p	R87I	0	.	.	259	261	CGT	618	620	CGT	201;203;204	C,A;G;T	190,1;192;192	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5102	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2930	173.2	1	SNP	p	S88P	0	.	.	262	264	TCC	621	623	TCC	204;206;206	T;C;C	190;193;197	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3924	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2543	153.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1486	1488	GGC	213;209;206	G;G;C	199;193;188	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1284	1286	GCC	166;167;167	G;C;C	152;155;156	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1287	1289	ATG	169;169;171	A;T;G	161;159;159	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1299	1301	ACC	168;168;170	A;C;C	159;162;163	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1299	1301	ACC	168;168;170	A;C;C	159;162;163	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1800	1802	ACC	173;171;171	A,C;C;C	154,1;161;162	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1854	1856	GCG	180;179;181	G;C;G	167;167;169	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1854	1856	GCG	180;179;181	G;C;G	167;167;169	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1977	1979	GGT	140;139;141	G;G;T,C	129;130;129,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1986	1988	AGC	146;144;143	A,G;G;C	132,1;133;131	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3578	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2388	149.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2004	2006	CCG	131;131;131	C,G;C;GCCC,GGCCCC	97,5;96;92,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5470	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3036	179.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1614	1616	CCG	190;191;193	C;C;G	171;177;177	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2468	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1698	143.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	538	538	C	176	C	163	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	252	porB1a	984	280	90.85	porB1a.l15.c30.ctg.1	1104	20.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	849	851	AAT	11;10;10	A;A;T	11;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	252	porB1a	984	280	90.85	porB1a.l15.c30.ctg.1	1104	20.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	852	854	AAT	10;10;9	A;A;T	10;10;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	252	porB1a	984	280	90.85	porB1a.l15.c30.ctg.1	1104	20.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	876	878	GCA	12;12;12	G;C;A	11;12;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	252	porB1a	984	280	90.85	porB1a.l15.c30.ctg.1	1104	20.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	899	901	GTA	11;11;11	G;T;A	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	252	porB1a	984	280	90.85	porB1a.l15.c30.ctg.1	1104	20.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	908	908	A	11	A	11	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2680	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1585	167.7	0	.	p	.	0	I45L	NONSYN	133	135	ATT	393	395	CTT	207;207;210	C;T;T	199;197;202	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2680	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1585	167.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	888	890	AGA	228;224;227	A;G,A;A	209;204,2;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2680	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1585	167.7	1	SNP	p	G120K	1	.	.	358	360	AAG	618	620	AAG	221;222;218	A;A;G	210;211;207	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2680	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1585	167.7	1	SNP	p	A121N	1	.	.	361	363	AAC	621	623	AAC	219;219;215	A;A;C	210;212;202	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2680	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1585	167.7	1	SNP	p	N121D	0	.	.	361	363	AAC	621	623	AAC	219;219;215	A;A;C	210;212;202	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9644	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4820	199.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1040	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1018	101.4	1	SNP	p	V57M	1	.	.	169	171	ATG	496	498	ATG	224;226;224	A;T;G	213;216;213	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
